Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

SCR-6852

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Simcere

Drug class:

Selective estrogen receptor degrader

Related drugs:

ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	SCR-6852 Sensitive: C2 – Inclusion Criteria SCR-6852 Sensitive : C2	SCR-6852 Sensitive: C2 – Inclusion Criteria SCR-6852 Sensitive : C2
ER D538G	Estrogen Receptor Positive Breast Cancer	ER D538G	Estrogen Receptor Positive Breast Cancer	SCR-6852 Sensitive: D – Preclinical SCR-6852 Sensitive : D	SCR-6852 Sensitive: D – Preclinical SCR-6852 Sensitive : D
ER Y537S	Estrogen Receptor Positive Breast Cancer	ER Y537S	Estrogen Receptor Positive Breast Cancer	SCR-6852 Sensitive: D – Preclinical SCR-6852 Sensitive : D	SCR-6852 Sensitive: D – Preclinical SCR-6852 Sensitive : D
ER positive	Estrogen Receptor Positive Breast Cancer	ER positive	Estrogen Receptor Positive Breast Cancer	SCR-6852 Sensitive: D – Preclinical SCR-6852 Sensitive : D	SCR-6852 Sensitive: D – Preclinical SCR-6852 Sensitive : D